while the over-priced half drug interest doesn't sell well and $29M is taken out for stock options. 10% of all the profits also go to the inventor of the drug.
I think it is selling just fine. Will have a nice rollout into the pre-chemo market for the next several years. Oral once daily pill the helps save lives of cancer pts. There are worse investments, no?